Back
Henry Schein, Inc. (HSIC)
Health CareHSIC · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$88.50
+0.05%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$3.27
ROE
8.8%
Gross margin
31.2%
Debt/Equity
0.78x
Revenue growth
6.3%
Henry Schein, Inc. — company intelligence
Earnings surprises
Q2 2026$1.27 vs $1.26 est+0.7%
Q1 2026$1.32 vs $1.24 est+6.3%
Q4 2025$1.34 vs $1.33 est+1.1%
Q3 2025$1.38 vs $1.30 est+5.8%
Analyst consensus · 25 analysts
14 Buy10 Hold1 Sell
Updated Aug 13, 2026
Insider activity · 90 days
1 buy0 sellsnet +2,215 shares
DANIEL WILLIAM KBuy 2,215 · Jun 12, 2026
Recent SEC filings
8-K — Material event reportAug 4, 2026
10-Q — Quarterly reportAug 4, 2026
8-K — Material event reportJul 30, 2026
Latest news
What Are Wall Street Analysts' Target Price for Henry Schein Stock? — Yahoo · 5d ago
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110 — Benzinga · 1w ago
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates — Yahoo · 1w ago
3 Unpopular Stocks with Open Questions — Yahoo · 1w ago
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.